-+ 0.00%
-+ 0.00%
-+ 0.00%

Verastem says RAMP 201 shows durable benefit for AVMAPKI-FAKZYNJA in recurrent ovarian cancer

Reuters·04/10/2026 11:00:52

Please log in to view news